{"version":"1.0","type":"link","title":"Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial.","author_name":"Huang Y 외","author_url":"https://prs-insight.online/author/Huang%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167971","thumbnail_width":1200,"thumbnail_height":630}